Epitope mapping of mouse monoclonal antibodies to the ppUL83 lower matrix phosphoprotein of human cytomegalovirus

被引:0
作者
Zal, B
Booth, J
Chadwick, J
Baboonian, C
机构
[1] Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England
[2] Univ London St Georges Hosp, Sch Med, Dept Med Microbiol, London SW17 0RE, England
[3] Ctr Appl Microbiol Res, Salisbury, Wilts, England
基金
英国惠康基金;
关键词
epitope mapping; lower matrix protein;
D O I
10.1002/(SICI)1096-9071(199903)57:3<290::AID-JMV13>3.3.CO;2-R
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Of nine mouse monoclonal antibodies (MAbs) directed against the lower matrix protein (pp65; ppUL83) of human cytomegalovirus (HCMV), all immunoprecipitated the 65-kDa protein. Only five were reactive by Western blotting, however, and four of these mapped to linear antigenic epitopes located between amino acids 184-195 (MAb C6), 343-357 (MAb C11), 448-462 (MAb C5), and 448-459 (MAb C13). The epitope specificity of the fifth antibody (MAb C3) and the four that recognised nonlinear sites could not be determined. Competition binding studies using HCMV antigen extracted from productively infected human embryonic lung fibroblasts (HELF), in an enzyme immunoassay (EIA), showed that three of the antibodies reactive with linear epitopes and two of those reactive with conformational epitopes (MAbs C3, C6, C11, C14, and C18), were unique in their binding specificities. MAb C4 competed with MAb C8 and MAb C5 competed with MAb C13 for binding to ppUL83. One of the linear epitopes identified, corresponding to amino acids SAFVFPTKDVAL (MAb C6), was an epitope described previously for CD8(+) cytotoxic T lymphocytes. J. Med. Virol. 57:290-297, 1999. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:290 / 297
页数:8
相关论文
共 31 条
[1]   COMPLEMENT-INDEPENDENT NEUTRALIZING MONOCLONAL-ANTIBODY WITH DIFFERENTIAL REACTIVITY FOR STRAINS OF HUMAN CYTOMEGALO-VIRUS [J].
BABOONIAN, C ;
BLAKE, K ;
BOOTH, JC ;
WIBLIN, CN .
JOURNAL OF MEDICAL VIROLOGY, 1989, 29 (02) :139-145
[2]   STRUCTURAL AND IMMUNOLOGICAL CHARACTERIZATION OF THE INTRACELLULAR FORMS OF AN ABUNDANT 68000-MR HUMAN CYTOMEGALOVIRUS PROTEIN [J].
BRITT, WJ ;
VUGLER, L .
JOURNAL OF GENERAL VIROLOGY, 1987, 68 :1897-1907
[3]   COMPARISON OF RESTRICTION SITE POLYMORPHISMS AMONG CLINICAL ISOLATES AND LABORATORY STRAINS OF HUMAN CYTOMEGALOVIRUS [J].
CHANDLER, SH ;
MCDOUGALL, JK .
JOURNAL OF GENERAL VIROLOGY, 1986, 67 :2179-2192
[4]  
CHARPENTIER B, 1987, ANN MED INTERNE, V138, P334
[5]   Stably expressed antisense RNA to cytomegalovirus UL83 inhibits viral replication [J].
DalMonte, P ;
Bessia, C ;
Ripalti, A ;
Landini, MP ;
Topilko, A ;
Plachter, B ;
Virelizier, JL ;
Michelson, S .
JOURNAL OF VIROLOGY, 1996, 70 (04) :2086-2094
[6]   Human cytomegalovirus pp65 lower matrix phosphoprotein harbours two transplantable nuclear localization signals [J].
Gallina, A ;
Percivalle, E ;
Simoncini, L ;
Revello, MG ;
Gerna, G ;
Milanesi, G .
JOURNAL OF GENERAL VIROLOGY, 1996, 77 :1151-1157
[7]   COMPARISON OF DIFFERENT IMMUNOSTAINING TECHNIQUES AND MONOCLONAL-ANTIBODIES TO THE LOWER MATRIX PHOSPHOPROTEIN (PP65) FOR OPTIMAL QUANTITATION OF HUMAN CYTOMEGALOVIRUS ANTIGENEMIA [J].
GERNA, G ;
REVELLO, MG ;
PERCIVALLE, E ;
MORINI, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (05) :1232-1237
[8]   Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product [J].
Gilbert, MJ ;
Riddell, SR ;
Plachter, B ;
Greenberg, PD .
NATURE, 1996, 383 (6602) :720-722
[9]   THE LOWER MATRIX PROTEIN-PP65 IS THE PRINCIPAL VIRAL-ANTIGEN PRESENT IN PERIPHERAL-BLOOD LEUKOCYTES DURING AN ACTIVE CYTOMEGALOVIRUS-INFECTION [J].
GREFTE, JMM ;
VANDERGUN, BTF ;
SCHMOLKE, S ;
VANDERGIESSEN, M ;
VANSON, WJ ;
PLACHTER, B ;
JAHN, G ;
THE, TH .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :2923-2932
[10]   MULTIPLICITY DEPENDENT EXPRESSION OF THE PREDOMINANT PHOSPHOPROTEIN PP65 OF HUMAN CYTOMEGALO-VIRUS [J].
KLAGES, S ;
RUGER, B ;
JAHN, G .
VIRUS RESEARCH, 1989, 12 (02) :159-168